REVANCE THERAPEUTICS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of RTI for the last quarter is 63.24 M EUR, and it's 17.74% higher compared to the previous quarter. The net income of Q4 23 is -50.46 M EUR.